Literature DB >> 6299205

Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.

A L Claudy, J L Touraine, D Mitanne.   

Abstract

A new case of epidermodysplasia verruciformis (EV) is reported in a 35-year-old man characterized by multiple common warts, flat warts, psoriasis-form lesions, and pityriasis-versicolor-(PV) like lesions. There was no familial history, no mental retardation, and no malignant changes. Human papilloma virus type 8 was identified in PV-like lesions. Immunologic studies detected no abnormalities: Delayed skin tests, DNCB sensitization, levels of immunoglobulins, complement components, circulating immune complexes, number of circulating lymphocytes, lymphocyte membrane markers, proliferative responses to mitogens, Ts activity, and Ts subpopulations as detected by monoclonal antibodies were considered to be within normal limits. A treatment with a retinoid aromatic (RO 10-9359) improved the clinical status of the patient and did not modify the immune parameters.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299205     DOI: 10.1007/bf00403724

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  18 in total

1.  Epidermodysplasia verruciformis.

Authors:  S D Prystowsky; J H Herndon; R G Freeman; C Boudreau
Journal:  Am J Dis Child       Date:  1976-04

2.  Epidermodysplasia verruciformis-investigation of immune function in two cases.

Authors:  R B Dymock; I J Forbes; I Simmons; M Weldon
Journal:  Australas J Dermatol       Date:  1977-04       Impact factor: 2.875

3.  Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus?

Authors:  S Jablonska; G Orth; M Jarzabek-Chorzelska; G Rzesa; S Obałek; W Glinski; M Favre; O Croissant
Journal:  J Invest Dermatol       Date:  1979-03       Impact factor: 8.551

Review 4.  Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis.

Authors:  M A Lutzner
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

5.  Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis.

Authors:  M A Lutzner; C Blanchet-Bardon
Journal:  N Engl J Med       Date:  1980-05-08       Impact factor: 91.245

6.  UV-induced DNA repair synthesis in patients with epidermodysplasia verruciformis.

Authors:  M Proniewska; S Jablonska
Journal:  Dermatologica       Date:  1980

7.  Twenty-one years of follow-up studies of familial epidermodysplasia verruciformis.

Authors:  S Jabłońska; G Orth; M Jarzabek-Chorzelska; W Gliński; S Obałek; G Rzesa; O Croissant; M Favre
Journal:  Dermatologica       Date:  1979

8.  Vitamin A acid in benign and malignant epithelial tumours of the skin.

Authors:  W Bollag; F Ott
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1975 Jan 27-29

9.  A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients.

Authors:  M Lutzner; O Croissant; M F Ducasse; H Kreis; J Crosnier; G Orth
Journal:  J Invest Dermatol       Date:  1980-10       Impact factor: 8.551

10.  Epidermodysplasia verruciformis: viral particles in early malignant lesions.

Authors:  Y Yabe; M Yasui; N Yoshino; T Fujiwara; N Ohkuma; N Nohara
Journal:  J Invest Dermatol       Date:  1978-10       Impact factor: 8.551

View more
  5 in total

1.  Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata.

Authors:  E K Cardamakis; I G Kotoulas; D P Dimopoulos; E N Stathopoulos; J T Michopoulos; V A Tzingounis
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

2.  Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy.

Authors:  L O Kanerva; E Johansson; K M Niemi; J Lauharanta; O P Salo
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 3.  Roles of Infection in Psoriasis.

Authors:  Shihui Zhou; Zhirong Yao
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

4.  Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.

Authors:  P C van Voorst Vader; M C de Jong; R Blanken; C G Kallenberg; A Vermey; J M Scheres
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Identification and characterization of eleven novel human gamma-papillomavirus isolates from healthy skin, found at low frequency in a normal population.

Authors:  Jingjing Li; YaQi Pan; QiuJu Deng; Hong Cai; Yang Ke
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.